Answer
When co-administered with ixazomib citrate, rifampicin decreases ixazomib Cmax by 54% and AUC by 74%; co-administration with strong CYP3A inducers is therefore not recommended.
Sources for this answer
- Ixazomib 4 mg hard capsulesTakeda UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 20Document updated
Sources checked